| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
18.62 |
% |
10.6019/CHEMBL4513141 |
| Bacillus anthracis |
Anthrax lethal factor |
FC |
3.1 |
None |
10.1128/aac.01184-06 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
0.01 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Cavia porcellus |
EC25 |
1.85 |
ug ml-1 |
10.1021/jm00152a013 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Voltage-dependent L-type calcium channel subunit alpha-1C |
IC50 |
1800.0 |
nM |
10.1002/jat.2784 |
| Cavia porcellus |
Voltage-dependent L-type calcium channel subunit alpha-1C |
IC50 |
1800.0 |
nM |
10.1093/cvr/cvr044 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-5.76 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
8.72 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
7799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
7100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
380.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
354.0 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
205.0 |
nM |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
52.0 |
nM |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
36.0 |
nM |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
424.0 |
nM |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
318.0 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
53700.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
58.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCRF-CEM |
ED50 |
0.29 |
uM l-1 |
10.1021/jm960384x |
| Homo sapiens |
CCRF-CEM |
ED50 |
3.55 |
uM l-1 |
10.1021/jm960384x |
| Homo sapiens |
CCRF-CEM |
ED50 |
88.0 |
nM |
10.1021/jm00014a031 |
| Homo sapiens |
CCRF-CEM |
RP |
16.0 |
None |
10.1021/jm00014a031 |
| Homo sapiens |
CCRF-CEM |
Uptake |
65.0 |
% |
10.1021/jm00014a031 |
| Homo sapiens |
CCRF-CEM/VCR-1000 |
IC50 |
1080.0 |
nM |
10.1021/jm030876r |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
3292.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
4603.4 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
12.0 |
% |
10.1021/jm300286a |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
25.0 |
% |
10.1021/jm300286a |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 51 |
IC50 |
200000.0 |
nM |
10.1124/dmd.106.013888 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
6599.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
1868.0 |
nM |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
1484.0 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
17000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
H4 |
Activity |
62.87 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
78.75 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
99.78 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
99.88 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
102.73 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
113.22 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
114.56 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
114.69 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
210.4 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
271.21 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
385.97 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
HEK293 |
Potency |
1157.7 |
nM |
None |
| Homo sapiens |
Hepatocyte |
CL |
47.8 |
uL.min-1.(10^6cells)-1 |
10.1124/dmd.111.042309 |
| Homo sapiens |
HepG2 |
IC50 |
nan |
None |
10.1016/j.ejmech.2020.113028 |
| Homo sapiens |
HERG |
AC50 |
660.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
440.0 |
nM |
10.1093/cvr/cvr044 |
| Homo sapiens |
HERG |
IC50 |
800.0 |
nM |
10.1016/j.bmcl.2004.06.070 |
| Homo sapiens |
HERG |
IC50 |
2880.0 |
nM |
10.1021/jm2005546 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Inhibition |
96.9 |
% |
10.1021/jm2005546 |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-19.31 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
12.03 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
CL |
10.0 |
mL.min-1.kg-1 |
10.1124/dmd.111.042309 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Vdss |
3.6 |
L.kg-1 |
10.1016/j.ejmech.2009.06.004 |
| Homo sapiens |
Huh-7 |
CC50 |
28860.0 |
nM |
10.1073/pnas.0802982105 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Inward rectifier potassium channel 2 |
Inhibition |
0.2 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Kir3.1/Kir3.4 |
Inhibition |
46.4 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Kir3.1/Kir3.4 |
Inhibition |
60.6 |
% |
10.1021/acs.jnatprod.8b00500 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver |
CL |
260.0 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
Liver |
Stability |
0.0 |
% |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
Liver |
T1/2 |
0.08833 |
hr |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
Liver microsomes |
CL |
4.0 |
mL.min-1.kg-1 |
10.1021/jm300286a |
| Homo sapiens |
Liver microsomes |
CL |
4.4 |
mL.min-1.kg-1 |
10.1021/jm2005546 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
8100.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
3016.0 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
2991.0 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
651.3 |
nM |
None |
| Homo sapiens |
Nuclear receptor subfamily 2 group E member 1 |
EC50 |
47000.0 |
nM |
10.1021/acs.jmedchem.1c00733 |
| Homo sapiens |
Nuclear receptor subfamily 2 group E member 1 |
EC50 |
nan |
None |
10.1021/acs.jmedchem.1c00733 |
| Homo sapiens |
Nuclear receptor subfamily 2 group E member 1 |
FC |
0.2 |
None |
10.1021/acs.jmedchem.1c00733 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
31.0 |
% |
10.1016/j.bmc.2009.02.002 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
40.0 |
% |
10.1016/j.bmc.2009.02.002 |
| Homo sapiens |
P-glycoprotein 1 |
EC50 |
320.0 |
nM |
10.1021/jm980121y |
| Homo sapiens |
P-glycoprotein 1 |
EC50 |
329.0 |
nM |
10.1021/jm060604z |
| Homo sapiens |
P-glycoprotein 1 |
EC50 |
331.13 |
nM |
10.6019/CHEMBL2449286 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
331.13 |
nM |
10.1021/jm201705f |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
4200.0 |
nM |
10.1021/jm020941h |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Potassium channel subfamily K member 2 |
IC50 |
7600.0 |
nM |
10.1021/acs.jmedchem.5b00671 |
| Homo sapiens |
Potassium channel subfamily K member 3 |
IC50 |
5100.0 |
nM |
10.1021/acs.jmedchem.5b00671 |
| Homo sapiens |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 |
Inhibition |
47.8 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
Inhibition |
54.6 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
150.0 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
1062.1 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
16481.6 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
26121.6 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
654.0 |
nM |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
187.0 |
nM |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
9600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
92.0 |
nM |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
58.0 |
nM |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
4100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
384.0 |
nM |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
201.0 |
nM |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
1863.0 |
nM |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
865.0 |
nM |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
2610.0 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
1097.0 |
nM |
None |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
3140.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
IC50 |
1190.0 |
nM |
10.1093/cvr/cvr044 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
IC50 |
3300.0 |
nM |
10.1021/jm2005546 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
IC50 |
5000.0 |
nM |
10.1021/jm2005546 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
Inhibition |
93.4 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
Inhibition |
97.1 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
11100.0 |
nM |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
15540.0 |
nM |
10.1021/acs.jmedchem.6b01317 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
83.8 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Ratio |
1.26 |
None |
10.1021/acs.jmedchem.6b01317 |
| Homo sapiens |
Sulfonylurea receptor 2, Kir6.2 |
IC50 |
2200.0 |
nM |
10.1021/jm2005546 |
| Homo sapiens |
Sulfonylurea receptor 2, Kir6.2 |
Inhibition |
89.6 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
2238.7 |
nM |
None |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
4598.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9174.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
11885.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
14963.1 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
12600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
Inhibition |
72.5 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv1.5 |
Inhibition |
65.4 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv4.3 |
Inhibition |
44.1 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
60.2 |
% |
10.1021/jm2005546 |
| Homo sapiens |
Whole blood |
Retention_time |
5.88 |
min |
10.1007/s00044-012-9977-1 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
6.97 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
L5178Y |
EC50 |
nan |
nM |
10.1021/jm980121y |
| Mus musculus |
Liver |
CL |
45.9 |
mL.min-1.kg-1 |
10.1021/jm2005546 |
| Mus musculus |
Liver |
CL |
46.0 |
mL.min-1.kg-1 |
10.1021/jm300286a |
| Mus musculus |
Mus musculus |
ED50 |
24.3 |
mg.kg-1 |
10.1021/jm00152a013 |
| Mus musculus |
Mus musculus |
LD50 |
605.0 |
mg.kg-1 |
10.1021/jm300286a |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Cholesteryl ester transfer protein |
Inhibition |
0.0 |
% |
10.1016/j.ejmech.2009.12.070 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
116.5 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
200.0 |
nM |
10.1021/jm2005546 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
252.1 |
nM |
10.1073/pnas.0802982105 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
920.0 |
nM |
10.1021/jm2005546 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
1000.0 |
nM |
10.1021/jm2005546 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
2690.0 |
nM |
10.1021/jm2005546 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
674.6 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
13.87 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
6147.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
2488.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
2558.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
1416.0 |
nM |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver microsome |
CL |
444.0 |
mL.min-1.g-1 |
10.1016/j.bmc.2014.12.007 |
| Rattus norvegicus |
Liver microsome |
T1/2 |
0.05167 |
hr |
10.1016/j.bmc.2014.12.007 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
9992.4 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
25574.8 |
nM |
None |
| Rattus norvegicus |
Plasma |
logFu |
0.05 |
None |
10.1016/j.ejmech.2009.06.004 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-11.7 |
% |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.7 |
mg.kg-1 |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
Heart rate |
391.0 |
beats min-1 |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
Heart rate |
443.0 |
beats min-1 |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
Heart rate |
445.0 |
beats min-1 |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
Increase |
13.8 |
% |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
VF |
25.0 |
% |
10.1021/jm00152a013 |
| Rattus norvegicus |
Rattus norvegicus |
VF |
50.0 |
% |
10.1021/jm00152a013 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
1637.0 |
nM |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
935.0 |
nM |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
562.3 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
794.3 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2048 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
9.33 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
CL |
0.0956 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.8b01065 |
| None |
ADMET |
CL |
0.19 |
mL.min-1.kg-1 |
10.1039/C8MD00556G |
| None |
ADMET |
CL |
0.2323 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.1c01970 |
| None |
ADMET |
CL |
1.184 |
mL.min-1.kg-1 |
10.1039/C8MD00556G |
| None |
ADMET |
CL |
4.62 |
mL.min-1.g-1 |
10.1016/j.ejmech.2022.114573 |
| None |
ADMET |
CL |
5.92 |
mL.min-1.g-1 |
10.1016/j.ejmech.2022.114573 |
| None |
ADMET |
CL |
8.8 |
mL.min-1.kg-1 |
10.1124/dmd.105.006619 |
| None |
ADMET |
CL |
16.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
30.8 |
mL.min-1.kg-1 |
10.1124/dmd.105.006619 |
| None |
ADMET |
CL |
38.02 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
44.1 |
mL.min-1.kg-1 |
10.1124/dmd.105.006619 |
| None |
ADMET |
CL |
62.0 |
mL.min-1.kg-1 |
10.1124/dmd.105.006619 |
| None |
ADMET |
CL |
106.3 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.8b01065 |
| None |
ADMET |
CL |
144.4 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.1c01366 |
| None |
ADMET |
CL |
160.4 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.1c01366 |
| None |
ADMET |
CL |
162.8 |
mL.min-1.kg-1 |
10.1039/C8MD00197A |
| None |
ADMET |
CL |
166.1 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.9b00010 |
| None |
ADMET |
CL |
170.2 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01023 |
| None |
ADMET |
CL |
173.8 |
mL.min-1.kg-1 |
10.1016/j.bmcl.2019.03.005 |
| None |
ADMET |
CL |
180.9 |
mL.min-1.g-1 |
10.1039/C8MD00197A |
| None |
ADMET |
CL |
184.5 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.9b00010 |
| None |
ADMET |
CL |
189.1 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.0c01023 |
| None |
ADMET |
CL |
193.2 |
mL.min-1.g-1 |
10.1016/j.bmcl.2019.03.005 |
| None |
ADMET |
CL |
194.3 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.8b00929 |
| None |
ADMET |
CL |
203.8 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.8b01300 |
| None |
ADMET |
CL |
204.2 |
mL.min-1.kg-1 |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
CL |
209.1 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.1c01970 |
| None |
ADMET |
CL |
219.6 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.9b01269 |
| None |
ADMET |
CL |
226.4 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.8b01300 |
| None |
ADMET |
CL |
226.9 |
mL.min-1.g-1 |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
CL |
231.9 |
mL.min-1.kg-1 |
10.1016/j.ejmech.2020.112085 |
| None |
ADMET |
CL |
235.3 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.1c00987 |
| None |
ADMET |
CL |
239.3 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.9b01769 |
| None |
ADMET |
CL |
251.5 |
mL.min-1.kg-1 |
10.1016/j.ejmech.2021.113848 |
| None |
ADMET |
CL |
257.7 |
mL.min-1.g-1 |
10.1016/j.ejmech.2020.112085 |
| None |
ADMET |
CL |
265.9 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.9b01769 |
| None |
ADMET |
CL |
279.5 |
mL.min-1.g-1 |
10.1016/j.ejmech.2021.113848 |
| None |
ADMET |
CL |
279.5 |
mL.min-1.g-1 |
10.1016/j.ejmech.2021.113903 |
| None |
ADMET |
CL |
328.0 |
mL.min-1.kg-1 |
10.1124/dmd.111.042309 |
| None |
ADMET |
CL |
488.5 |
mL.min-1.g-1 |
10.1016/j.ejmech.2021.114045 |
| None |
ADMET |
CL |
495.4 |
mL.min-1.g-1 |
10.1016/j.ejmech.2021.114045 |
| None |
ADMET |
CL |
668.1 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.0c01647 |
| None |
ADMET |
CL |
1047.3 |
mL.min-1.g-1 |
10.1016/j.ejmech.2020.113028 |
| None |
ADMET |
CL |
1145.8 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.9b01269 |
| None |
ADMET |
CL |
1885.1 |
mL.min-1.g-1 |
10.1016/j.ejmech.2020.113028 |
| None |
ADMET |
CL |
2433.0 |
mL.min-1.kg-1 |
10.1016/j.bmcl.2021.128420 |
| None |
ADMET |
CL |
2433.0 |
mL.min-1.kg-1 |
10.1016/j.ejmech.2021.113337 |
| None |
ADMET |
CL |
2645.6 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01647 |
| None |
ADMET |
CL |
251500.0 |
mL.min-1.g-1 |
10.1016/j.ejmech.2021.113903 |
| None |
ADMET |
CLH |
211.1 |
uL/min |
10.1039/C8MD00556G |
| None |
ADMET |
CLH |
215.9 |
uL/min |
10.1021/acs.jmedchem.8b00929 |
| None |
ADMET |
CLH |
657.9 |
uL/min |
10.1039/C8MD00556G |
| None |
ADMET |
delta logD |
-0.89 |
None |
10.1021/jm0000564 |
| None |
ADMET |
EFTPC |
133.5 |
nM |
10.1093/cvr/cvr044 |
| None |
ADMET |
eLog D |
1.49 |
None |
10.1021/jm0200409 |
| None |
ADMET |
F |
49.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
Fraction ionised |
0.987 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fu |
0.005 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fu |
0.05 |
None |
10.1021/jm0200409 |
| None |
ADMET |
Fu |
0.05 |
None |
10.1021/jm030408h |
| None |
ADMET |
Fu |
0.059 |
None |
10.1124/dmd.111.042309 |
| None |
ADMET |
MRT |
2.2 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
permeability |
1500.0 |
ucm/s |
10.1021/jm300286a |
| None |
ADMET |
PPB |
92.95 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
95.91 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio IC50/EC50 |
3.0 |
None |
10.1021/jm2005546 |
| None |
ADMET |
Stability |
0.0 |
% |
10.1016/j.ejmech.2019.111841 |
| None |
ADMET |
Stability |
0.0 |
% |
10.1016/j.ejmech.2021.113848 |
| None |
ADMET |
Stability |
0.0 |
% |
10.1016/j.ejmech.2021.113903 |
| None |
ADMET |
Stability |
0.0 |
% |
10.1021/acs.jmedchem.0c01647 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1016/j.ejmech.2020.112085 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1016/j.ejmech.2020.112423 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1021/acs.jmedchem.1c01970 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1021/acs.jmedchem.8b01300 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1021/acs.jmedchem.9b01269 |
| None |
ADMET |
Stability |
0.1 |
% |
10.1021/acs.jmedchem.9b01769 |
| None |
ADMET |
Stability |
0.2 |
% |
10.1021/acs.jmedchem.8b00929 |
| None |
ADMET |
Stability |
0.2 |
% |
10.1021/acs.jmedchem.9b01269 |
| None |
ADMET |
Stability |
0.2 |
% |
10.1039/C8MD00556G |
| None |
ADMET |
Stability |
0.3 |
% |
10.1016/j.bmcl.2019.03.005 |
| None |
ADMET |
Stability |
0.3 |
% |
10.1016/j.ejmech.2019.111841 |
| None |
ADMET |
Stability |
0.3 |
% |
10.1016/j.ejmech.2020.112423 |
| None |
ADMET |
Stability |
0.3 |
% |
10.1039/C8MD00556G |
| None |
ADMET |
Stability |
0.4 |
% |
10.1016/j.ejmech.2020.113028 |
| None |
ADMET |
Stability |
0.4 |
% |
10.1021/acs.jmedchem.0c01023 |
| None |
ADMET |
Stability |
0.4 |
% |
10.1021/acs.jmedchem.9b00010 |
| None |
ADMET |
Stability |
0.5 |
% |
10.1039/C8MD00197A |
| None |
ADMET |
Stability |
0.6 |
% |
10.1021/acs.jmedchem.1c01366 |
| None |
ADMET |
Stability |
0.9 |
% |
10.1016/j.ejmech.2020.112423 |
| None |
ADMET |
Stability |
4.3 |
% |
10.1021/acs.jmedchem.8b01065 |
| None |
ADMET |
Stability |
38.7 |
% |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
Stability |
39.9 |
% |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
Stability |
63.4 |
% |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
Stability |
70.7 |
% |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
Stability |
81.3 |
% |
10.1021/acs.jmedchem.1c01366 |
| None |
ADMET |
Stability |
90.1 |
% |
10.1021/acs.jmedchem.8b00929 |
| None |
ADMET |
Stability |
93.6 |
% |
10.1016/j.ejmech.2021.113848 |
| None |
ADMET |
Stability |
93.6 |
% |
10.1016/j.ejmech.2021.113903 |
| None |
ADMET |
Stability |
95.6 |
% |
10.1021/acs.jmedchem.8b01300 |
| None |
ADMET |
Stability |
97.9 |
% |
10.1016/j.ejmech.2020.112085 |
| None |
ADMET |
Stability |
98.0 |
% |
10.1016/j.ejmech.2020.113028 |
| None |
ADMET |
Stability |
104.2 |
% |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
Stability |
104.5 |
% |
10.1021/acs.jmedchem.8b01065 |
| None |
ADMET |
Stability |
105.5 |
% |
10.1021/acs.jmedchem.0c01647 |
| None |
ADMET |
T1/2 |
0.02 |
hr |
10.1016/j.ejmech.2020.112423 |
| None |
ADMET |
T1/2 |
0.02 |
hr |
10.1016/j.ejmech.2021.113567 |
| None |
ADMET |
T1/2 |
0.02 |
hr |
10.1021/acs.jmedchem.9b01269 |
| None |
ADMET |
T1/2 |
0.02167 |
hr |
10.1016/j.ejmech.2020.113028 |
| None |
ADMET |
T1/2 |
0.02333 |
hr |
10.1016/j.ejmech.2020.112423 |
| None |
ADMET |
T1/2 |
0.02333 |
hr |
10.1016/j.ejmech.2021.113567 |
| None |
ADMET |
T1/2 |
0.035 |
hr |
10.1021/acs.jmedchem.0c01647 |
| None |
ADMET |
T1/2 |
0.035 |
hr |
10.1039/C8MD00556G |
| None |
ADMET |
T1/2 |
0.03833 |
hr |
10.1016/j.bmcl.2021.128420 |
| None |
ADMET |
T1/2 |
0.03833 |
hr |
10.1016/j.ejmech.2021.113337 |
| None |
ADMET |
T1/2 |
0.04667 |
hr |
10.1016/j.ejmech.2019.111841 |
| None |
ADMET |
T1/2 |
0.04667 |
hr |
10.1016/j.ejmech.2021.114045 |
| None |
ADMET |
T1/2 |
0.08333 |
hr |
10.1016/j.ejmech.2021.113848 |
| None |
ADMET |
T1/2 |
0.08333 |
hr |
10.1016/j.ejmech.2021.113903 |
| None |
ADMET |
T1/2 |
0.08667 |
hr |
10.1021/acs.jmedchem.9b01769 |
| None |
ADMET |
T1/2 |
0.09 |
hr |
10.1016/j.ejmech.2020.112085 |
| None |
ADMET |
T1/2 |
0.09833 |
hr |
10.1021/acs.jmedchem.1c00987 |
| None |
ADMET |
T1/2 |
0.1 |
hr |
10.1021/acs.jmedchem.1c01970 |
| None |
ADMET |
T1/2 |
0.1017 |
hr |
10.1016/j.bmcl.2018.09.014 |
| None |
ADMET |
T1/2 |
0.1017 |
hr |
10.1016/j.ejmech.2019.111841 |
| None |
ADMET |
T1/2 |
0.1017 |
hr |
10.1021/acs.jmedchem.8b01300 |
| None |
ADMET |
T1/2 |
0.105 |
hr |
10.1021/acs.jmedchem.9b01269 |
| None |
ADMET |
T1/2 |
0.1067 |
hr |
10.1021/acs.jmedchem.8b00929 |
| None |
ADMET |
T1/2 |
0.11 |
hr |
10.1039/C8MD00556G |
| None |
ADMET |
T1/2 |
0.12 |
hr |
10.1016/j.bmcl.2019.03.005 |
| None |
ADMET |
T1/2 |
0.1217 |
hr |
10.1021/acs.jmedchem.0c01023 |
| None |
ADMET |
T1/2 |
0.125 |
hr |
10.1021/acs.jmedchem.9b00010 |
| None |
ADMET |
T1/2 |
0.1283 |
hr |
10.1039/C8MD00197A |
| None |
ADMET |
T1/2 |
0.1433 |
hr |
10.1016/j.ejmech.2020.112423 |
| None |
ADMET |
T1/2 |
0.1433 |
hr |
10.1016/j.ejmech.2021.113567 |
| None |
ADMET |
T1/2 |
0.2183 |
hr |
10.1021/acs.jmedchem.8b01065 |
| None |
ADMET |
T1/2 |
1.95 |
hr |
10.1016/j.ejmech.2022.114573 |
| None |
ADMET |
T1/2 |
2.1 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
2.5 |
hr |
10.1016/j.ejmech.2022.114573 |
| None |
ADMET |
T1/2 |
8.6 |
hr |
10.1021/acs.jmedchem.1c01366 |
| None |
ADMET |
Vdss |
2.2 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
2.29 |
L.kg-1 |
10.1124/dmd.105.006619 |
| None |
ADMET |
Vdss |
3.0 |
L.kg-1 |
10.1124/dmd.105.006619 |
| None |
ADMET |
Vdss |
3.6 |
L.kg-1 |
10.1021/jm0200409 |
| None |
ADMET |
Vdss |
3.6 |
L.kg-1 |
10.1021/jm030408h |
| None |
ADMET |
Vdss |
5.2 |
mL/min/kg |
10.1124/dmd.105.006619 |
| None |
ADMET |
Vdss |
8.2 |
L.kg-1 |
10.1124/dmd.105.006619 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
7.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
3.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
2.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
4.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
1.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
5.7 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
4.7 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.038 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Fu |
0.783 |
None |
10.1124/dmd.111.042309 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
7.7 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
7.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
10.6 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
CLogP |
3.36 |
None |
10.1021/jm030876r |
| None |
No relevant target |
CLogP |
3.39 |
None |
10.1021/jm030876r |
| None |
No relevant target |
LogD |
0.15 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD |
1.6 |
None |
10.1021/jm8005228 |
| None |
No relevant target |
LogD |
1.77 |
None |
10.1021/jm8005228 |
| None |
No relevant target |
LogD |
1.81 |
None |
10.1021/jm0100990 |
| None |
No relevant target |
LogD7.4 |
1.72 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Log Kmemb |
0.7 |
None |
10.1021/jm0309001 |
| None |
No relevant target |
LogP |
3.36 |
None |
10.1021/jm960384x |
| None |
No relevant target |
LogP |
4.615 |
None |
10.1124/dmd.111.042309 |
| None |
No relevant target |
pKa |
8.8 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
9.0 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
9.2 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
pKa |
9.27 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
9.27 |
None |
10.1016/j.ejmech.2009.06.004 |
| None |
No relevant target |
pKa |
9.27 |
None |
10.1021/jm0200409 |
| None |
No relevant target |
pKa |
9.27 |
None |
10.1021/jm030408h |
| None |
No relevant target |
pKa |
9.3 |
None |
10.1124/dmd.111.042309 |
| None |
No relevant target |
pKa |
9.31 |
None |
10.1021/jm020941h |
| None |
No relevant target |
pKa |
9.48 |
None |
10.1124/dmd.112.050278 |
| None |
No relevant target |
Solubility |
69800.0 |
nM |
10.1021/jm2005546 |
| None |
No relevant target |
Solubility |
70000.0 |
nM |
10.1021/jm300286a |
| None |
Unchecked |
Ac50 |
0.04324 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.1367 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.1534 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.931 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.239 |
uM |
None |
| None |
Unchecked |
Ac50 |
7.689 |
uM |
None |
| None |
Unchecked |
Ac50 |
8.627 |
uM |
None |
| None |
Unchecked |
Ac50 |
8.913 |
uM |
None |
| None |
Unchecked |
Ac50 |
9.68 |
uM |
None |
| None |
Unchecked |
Ac50 |
10.86 |
uM |
None |
| None |
Unchecked |
Ac50 |
11.22 |
uM |
None |
| None |
Unchecked |
AC50 |
2238.7 |
nM |
None |
| None |
Unchecked |
AC50 |
7943.3 |
nM |
None |
| None |
Unchecked |
AC50 |
8627.5 |
nM |
None |
| None |
Unchecked |
AC50 |
8912.5 |
nM |
None |
| None |
Unchecked |
AC50 |
8920.0 |
nM |
None |
| None |
Unchecked |
AC50 |
9680.2 |
nM |
None |
| None |
Unchecked |
AC50 |
11220.2 |
nM |
None |
| None |
Unchecked |
AC50 |
12186.6 |
nM |
None |
| None |
Unchecked |
AC50 |
14125.4 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
9.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
6.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
775.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1299.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1744.0 |
nM |
None |
| None |
Unchecked |
IC50 |
4918.82 |
nM |
None |
| None |
Unchecked |
IC50 |
5346.02 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
33330.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
IFI |
0.5495 |
% |
10.1073/pnas.0802982105 |
| None |
Unchecked |
Inhibition |
33.0 |
% |
10.1021/jm2005546 |
| None |
Unchecked |
Ki |
689.0 |
nM |
None |
| None |
Unchecked |
Ki |
1185.0 |
nM |
None |
| None |
Unchecked |
Ki |
1695.0 |
nM |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
1778.3 |
nM |
None |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
8196.1 |
nM |
None |
| None |
Unchecked |
Potency |
8912.5 |
nM |
None |
| None |
Unchecked |
Potency |
9200.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
28183.8 |
nM |
None |
| None |
Unchecked |
Potency |
28695.4 |
nM |
None |